# United States Pre-Market Tobacco Application Pharmacokinetics

> **NCT03719391** · NA · COMPLETED · sponsor: **Juul Labs, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Nicotine Dependence
- Nicotine Dependence, Cigarettes
- Tobacco Use
- Tobacco Smoking

## Interventions

- **OTHER:** Virginia Tobacco flavored JUUL 5% ENDS
- **OTHER:** Cool Mint flavored JUUL 5% ENDS
- **OTHER:** Mango flavored JUUL 5% ENDS
- **OTHER:** Creme Brulee flavored JUUL 5% ENDS
- **OTHER:** VUSE Solo e-cigarette
- **OTHER:** Nicorette White Ice Mint 4mg nicotine polacrilex gum
- **OTHER:** Usual Brand combustible cigarette

## Key facts

- **NCT ID:** NCT03719391
- **Lead sponsor:** Juul Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-19
- **Primary completion:** 2018-11-21
- **Final completion:** 2018-11-28
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03719391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03719391, "United States Pre-Market Tobacco Application Pharmacokinetics". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03719391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*